Because IDO1 activity leads to degradation of TRP in the TME, we measured the level of TRP in the culture medium after T cell treatment of melanoma cultures at a 1:10 T cell:tumor ratio, where we observed the biggest range of tumor sensitivities. The gene discussed is IDO1; the disease is melanoma.